+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Laboratory and clinical studies on cefamandole in pediatric field



Laboratory and clinical studies on cefamandole in pediatric field



Japanese Journal of Antibiotics 32(11): 1091-1100



Laboratory and clinical studies were performed on a new semisynthetic cephalosporin, cefamandole (CMD), and following results were obtained. (1) Serum concentrations and urinary recovery rates of CMD were determined after an intravenous administration of CMD 30 mg/kg in 13 children with normal renal function. In 5 of 13 children, mean serum levels after a one shot intravenous injection were 112.5 micrograms/ml at 15 minutes, 52.2 micrograms/ml at 30 minutes, 23.3 micrograms/ml at 1 hour, 4.9 micrograms/ml at 2 hours and trace at 4 hours. In other 5 children, mean serum levels after drip infusion for 1 hour were 78 micrograms/ml at 30 minutes, 59 micrograms/ml at 1 hour, 9.8 micrograms/ml at 2 hours and trace at 4 hours, after the onset of drip infusion. In the remaining 3 children who received CMD by drip infusion for 2 hours, mean serum levels were 24.3 micrograms/ml at 30 minutes, 35.3 micrograms/ml at 1 hour, 30.2 micrograms/ml at 2 hours, 5.3 micrograms/ml at 3 hours and 1.5 micrograms/ml at 4 hours after the onset of drip infusion. Urinary recovery rates in 5 children were 154.7%, 98.3%, 93.2%, 111.8% and 66.9%, respectively, during 8 hours. (2) CMD was administered to 40 patients with various infections (acute U.T.I. 8, acute angina lacunaris; 2, acute bronchitis; 5, cervical purulent lymphadenitis; 2, post-measles bronchopneumonia; 3, acute bronchopneumonia; 18, pyothorax; 2, S.S.S. syndrome; 1) by one-shot intravenous injection at a dose of 40-120 mg/kg per day. The clinical efficacy rate was 92.5% and bacteriological efficacy rate was 79.2%. (3) As the side effect of CMD, eosinophilia was observed in 1 case, rash and elevation of GOT and GPT in 1 case, and proteinuria in 1 case.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 059905256

Download citation: RISBibTeXText

PMID: 513291


Related references

Laboratory and clinical study of cefamandole by intravenous injection in the pediatric field. Japanese Journal of Antibiotics 32(11): 1081-1090, 1979

Laboratory and clinical studies of cefamandole in pediatric infections. Japanese Journal of Antibiotics 33(4): 429-432, 1980

Laboratory and clinical studies on cefamandole. Japanese Journal of Antibiotics 32(9): 890-900, 1979

Laboratory and clinical studies of cefamandole in children. Japanese Journal of Antibiotics 32(9): 938-951, 1979

Laboratory and clinical studies of PC-904 in pediatric field. Japanese Journal of Antibiotics 31(7): 359-362, 1978

Fundamental and clinical studies on cefamandole in pediatric treatment. Japanese Journal of Antibiotics 32(9): 930-937, 1979

Laboratory and clinical studies of sultamicillin in pediatric field. Japanese Journal of Antibiotics 41(12): 1923-1939, 1988

Laboratory and clinical studies cefroxadine in pediatric field. Japanese Journal of Antibiotics 34(12): 1655-1662, 1981

Laboratory and clinical studies of aztreonam in the pediatric field. Japanese Journal of Antibiotics 38(11): 3300-3306, 1985

Laboratory and clinical studies on aztreonam in the pediatric field. Japanese Journal of Antibiotics 38(11): 3343-3348, 1985

Laboratory and clinical studies on cefdinir in pediatric field. Japanese Journal of Antibiotics 43(8): 1424-1435, 1990

Laboratory and clinical studies on cefoxitin in pediatric field. Japanese Journal of Antibiotics 34(3): 287-304, 1981

Laboratory and clinical studies on norfloxacin in the pediatric field. Japanese Journal of Antibiotics 43(5): 808-825, 1990

Laboratory and clinical studies on cefminox in the pediatric field. Japanese Journal of Antibiotics 38(3): 766-772, 1985

Laboratory and clinical studies of cefminox in the pediatric field. Japanese Journal of Antibiotics 38(3): 730-736, 1985